secwatch.observer — SEC 8-K summary
======================================

Issuer:     CHINA PHARMA HOLDINGS, INC. (CPHI)
CIK:        0001106644
Form:       8-K
Filed at:   2021-12-29T23:59:59+00:00
Accession:  0001213900-21-067912
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Annual meeting elects five directors, approves incentive plan amendment
-----------------------------------------------------------------------

- Quorum of 55% (35,348,061 shares) present at Dec 26, 2021 annual meeting.
- All five director nominees elected: Zhilin Li, Heung Mei Tsui, Gene Michael Bennett, Yingwen Zhang, Baowen Dong.
- Amendment No.2 to 2010 Long-Term Incentive Plan approved (25,917,951 for, 94,918 against, 7,791 abstentions).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1106644/000121390021067912/0001213900-21-067912-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1106644/000121390021067912/ea153163-8k_chinapharma.htm
  HTML page:      https://secwatch.observer/filing/0001213900-21-067912

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer